ConductScience.org, home

Paper37597404

Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges.

Song X and 9 others. Int Immunopharmacol, 2023. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges. Papers, record 37597404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37597404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges.
PubMed
Journal
Int Immunopharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2023-09-22
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song XXueyi
2Li XXuehao
3Ge YYuexin
4Song JJia
5Wei QQian
6He MMiao
7Wei MMinjie
8Zhang YYining
9Chen TTianbao
10Zhao LLin

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alternative SplicingMajor topic
NeoplasmsMajor topic
Humans
Cell Differentiation
Inflammation
Tumor Microenvironment

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42843924TCASIA: an integrative atlas linking alternative splicing landscapes for cancer immunotherapy.J Immunother Cancer2026https://conductscience.org/library/papers/42843924PubMed
42574086Alternative Splicing in Cyclin-Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer.Drug Dev Res2026https://conductscience.org/library/papers/42574086PubMed
42350624The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.Cell Death Differ2026https://conductscience.org/library/papers/42350624PubMed
41580475Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.Clin Transl Oncol2026https://conductscience.org/library/papers/41580475PubMed
41286160Transcriptome study exploring the mechanisms linking pollutants and breast cancer aggressiveness.Sci Rep2025https://conductscience.org/library/papers/41286160PubMed
41268214Alternative Splicing: A Critical Regulator in Human Bone Biology and Tumor Progression.Research (Wash D C)2025https://conductscience.org/library/papers/41268214PubMed
41159202Alternative splicing immune signature for detecting HBV-related hepatocellular carcinoma in peripheral blood mononuclear cells.Biochem Biophys Rep2025https://conductscience.org/library/papers/41159202PubMed
40702000RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.Cell Death Discov2025https://conductscience.org/library/papers/40702000PubMed
39425166Alternative splicing in ovarian cancer.Cell Commun Signal2024https://conductscience.org/library/papers/39425166PubMed
39060340KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes.Sci Rep2024https://conductscience.org/library/papers/39060340PubMed
38752399Expression of Truncated Products at the 5'-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance.Genome Biol Evol2024https://conductscience.org/library/papers/38752399PubMed
38736877Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies.Front Immunol2024https://conductscience.org/library/papers/38736877PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37597404

GET https://conductscience.org/api/papers/v1/37597404/authors